All companies › IONS

IONS

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research signal for this company.

0
Open-market buys
0
Open-market sells
1
INSIDER SCANNER signals
—
Last filing

INSIDER SCANNER signals for IONS

Research signals this company has produced, with the reasoning recorded at the time.

B · nan conviction · nan · 2026-08-01
51.77Entry reference
56.95Model target
30.0Max hold (days)
15.0%Model allocation
Hayden Michael R · Dir

Director Hayden bought a large $1.06M block on Jul 30, lifting his stake 34%, and current price is actually 2.2% below where he bought — decent entry with RSI ~30 after a 37% drawdown. But this is director-only with zero C-suite, and fundamentals are weak: revenue down 40.7% YoY, negative gross margin, unprofitable, debt slightly exceeds cash. Healthcare sector is beating SPY by 8.3%, but the size

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.